Key Highlights

  • Gelion PLC (LSE:GELN) shares have rallied from around 12.5p in mid-October to about 20.5p by 3 November 2026, a gain of roughly 64% in a matter of weeks.
  • The company has signed agreements with two leading global automotive manufacturers, including a proof-of-concept agreement and a material transfer agreement.
  • Independent US testing of its Nano-Encapsulated Sulfur cathode material delivered strong preliminary results, sending the shares up 12.5% on the day.
  • Final results for the year to 30 June 2026 highlighted six new Patent grants and an expanded collaboration with TDK.
  • Chief executive Matt Wood will present at investor events on 11 November and 17 to 18 November, with the AGM on 17 November.

Why Gelion Is in Focus Today

Gelion PLC (LSE:GELN) has become one of the standout performers among battery technology stocks on the FTSE AIM All-Share as of 5 November 2026. The sulfur battery specialist has seen its shares rise from about 12.5p in mid-October to around 20.5p at the start of November, powered by a flurry of commercial and technical updates. That momentum has made LSE:GELN a trending name on investor forums and social media, where discussion has centred on whether the company is finally moving from research into commercial partnerships with major global players.

The rally has been built on substance rather than speculation alone. In the space of a few weeks, Gelion announced a material transfer agreement with a global automotive manufacturer, a proof-of-concept agreement with another major automaker, strong independent test results from the United States, and full-year results that confirmed a strengthened patent portfolio. On 3 November, the company also confirmed a programme of investor presentations, giving shareholders and prospective investors direct access to management during November.

What Gelion Does

Gelion is developing next-generation cathode technologies for lithium-ion and lithium-sulfur batteries. Its proprietary Nano-Encapsulated Sulfur, known as NES, is a cathode active material designed to replace conventional critical-mineral cathodes with abundant sulfur. Sulfur is low cost, widely available, mining-free and largely free from the Supply chain constraints that affect materials such as nickel and cobalt.

Crucially, NES is designed to drop into existing global battery Manufacturing lines. That means battery makers would not need to build new factories to use it, which could significantly lower the barrier to adoption. Gelion PLC (LSE:GELN) aims to commercialise NES through partnerships with industrial companies and battery manufacturers across automotive, defence, device and other high-performance applications.

A Busy October

On 6 October, Gelion announced a material transfer agreement with a global automotive manufacturer, allowing that company to evaluate NES samples. On 13 October, it followed up with a proof-of-concept agreement with another major automaker. In its third-quarter newsletter at the end of October, Gelion said it now works with a Top 15 global automotive manufacturer and a Top 5 global automotive manufacturer, alongside existing partners including TDK and Mitsui Kinzoku in Japan, QinetiQ and Nissan in the UK, the National Laboratory of the Rockies in the US and the Max Planck Institute of Colloids and Interfaces in Germany.

On 19 October, Gelion reported strong preliminary results from independent testing of its NES material in the United States. The shares rose 12.5% on the news, as independent validation is a key step in convincing manufacturers that the technology performs as claimed.

Full-Year Results

On 21 October, Gelion PLC (LSE:GELN) published audited results for the year ended 30 June 2026. The company highlighted six new patent grants, including three in the United States, two in Europe and one in Asia, strengthening protection for its sulfur battery technology across key markets. Management also pointed to strong testing results from the NES cathode platform, which supported an expansion of the scope of its collaboration agreement with TDK Corporation earlier in the year. The Annual Report was posted to shareholders on 23 October.

As a development-stage company, Gelion remains loss-making, with Revenue from grants, collaboration fees and development work. Its strategy is to secure licensing or supply arrangements that could generate meaningful Recurring Revenue once partners move towards commercial production.

Risks to Consider

Gelion's technology is not yet in commercial production, and evaluation agreements do not guarantee future supply or licensing deals. Battery qualification cycles in the automotive industry can take several years. The company is likely to need further funding to support scale-up, which could dilute shareholders. After a sharp rally, the shares may also be vulnerable to profit-taking.

What Investors Are Watching Next

In the near term, investors in Gelion PLC (LSE:GELN) will be watching the company's investor presentations on 11 November and 17 to 18 November, and the AGM on 17 November, for any additional commentary on Partnership progress. The company has flagged an upcoming milestone in an Australian Renewable Energy Agency funded project in the fourth quarter of 2026.

Beyond that, the key catalysts are findings from evaluations with the two new automotive manufacturers, any conversion of proof-of-concept work into joint development or licensing agreements, further independent validation results and an update on funding. If those milestones land, LSE:GELN could cement its position as one of the most exciting battery materials plays on the FTSE AIM All-Share.